A single-centre, open, randomised, three-way cross-over drug-drug interaction study of esomeprazole (D961H) capsule and loxoprofen tablet after repeated oral administration in Japanese healthy male subjects

Trial Profile

A single-centre, open, randomised, three-way cross-over drug-drug interaction study of esomeprazole (D961H) capsule and loxoprofen tablet after repeated oral administration in Japanese healthy male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2009

At a glance

  • Drugs Esomeprazole (Primary) ; Loxoprofen
  • Indications Gastro-oesophageal reflux; Pain
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 11 Mar 2009 Updated end date, from clinicaltrials.gov record.
    • 23 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top